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The HERV-K(HML-2) family is the most recent addition to the collection of human endogenous retro-
viruses. It comprises proviruses that encode functional proteins that can assemble into replication
defective particles carrying the envelope protein. Using a reconstituted HERV-K113 envelope sequence,
we have analyzed its ability to mediate entry into a set of 33 cell lines from 10 species. Of these, 30 were
permissive, demonstrating an amphotropism consistent with a broad expression of receptor protein(s).
In an initial effort to identify a receptor for HERV-K(HML-2) we investigated whether transferrin receptor
1 and hyaluronidase 2, known cellular receptors of the closely related betaretroviruses mouse mammary
tumor virus (MMTV) and Jaagsiekte sheep retrovirus (JSRV), could facilitate HERV-K(HML-2) entry.
However, neither of these proteins could serve as a receptor for HERV-K(HML-2). Moreover, during
attempts to further characterize the tropism of HERV-K(HML-2), we identiﬁed a cellular activity that
inhibits infection at a post-entry, pre-integration step.
& 2015 Elsevier Inc. All rights reserved.Introduction
Approximately 8% of the human genome consists of sequences
of ancient retroviral origin (Lander et al., 2001). These elements
are the outcome of germ line infections that have since been
transmitted vertically (Katzourakis et al., 2005). The retroviruses
that most recently became endogenized in our chromosomes
belong to the HERV-K(HML-2) family, designated here as HML-2
for brevity. The presence of HML-2 sequences at the same location
in the genomes of various Old World monkey lineages and in
humans and other apes and their absence in New World monkeys
as well as the identiﬁcation of human speciﬁc integrations provide
strong evidence that HML-2 was actively replicating for about 34
million years, resulting in over 3000 HML-2 integrations in the
human genome, including approximately 100 of full- or near full-
length (Subramanian et al., 2011). It is generally accepted that the
vast majority of these integrations are the result of de novo
infections of host cells by an actively replicating virus (Gifford
et al., 2005). The extent of postinsertional mutations and the fact
that not one of the catalogued HML-2 elements has the potential.to encode an infectious retrovirus indicates that, for unknown
reasons, this family stopped replicating between one and two
millions of years ago (Gifford et al., 2005; Subramanian et al.,
2011). Genetic drift and a lack of positive selection have led to the
inactivation of all HERVs currently known. Nevertheless, it remains
possible that a replication-competent HML-2 element does exist at
a very low frequency in the human population or that such an
element could be restored by recombination between partially
crippled sequences (Dewannieux et al., 2006).
HML-2 is transcriptionally active and is highly expressed in
many malignant cells, particularly teratocarcinomas (Lower et al.,
1984). Several of the full-length proviruses are known to encode
open reading frames for structural proteins and for the accessory
protein Rec. These include at least one element encoding a func-
tional HML-2 envelope protein and several encoding a functional
reverse transcriptase (Dewannieux et al., 2005). Expression of
HML-2 proteins and viral RNAs leads to the assembly and release
of maturation-competent virus-like particles, indicating that in
principle de novo infections into somatic or germ line cells can
occur by complementation in trans (Bannert and Kurth, 2006).
Along these lines HML-2 might beneﬁt from infection by other
retroviruses that provide functional envelope proteins able to
efﬁciently pseudotype HML-2-VLPs or provide other structural
proteins for the assembly of chimeric particles (Monde et al.,
2012). On the other hand, the HML-2 envelope has the ability to
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potentially endow them with an extended cell tropism (Hanke
et al., 2009; Lee and Bieniasz, 2007).
The receptor(s) originally used by HML-2 for entry remains
unknown and there is a paucity of data available concerning the
cell and species tropism of the virus. Using HML-2 Env pseudo-
typed lenti- or gammaretroviruses we and other groups have
achieved some level of entry into a few of the cell lines so far
tested (Contreras-Galindo et al., 2015; Dewannieux et al., 2005;
Hanke et al., 2009; Lee and Bieniasz, 2007). Somewhat more is
known about the susceptibility to inhibition by widely active cel-
lular antiretroviral factors that have been identiﬁed. For example,
VSV-G-pseudotyped HML-2 virions are inhibited by APOBEC 3F
and 3G but no inhibition is seen with Trim5α, despite the very low
infectivity rate of HML-2 virions compared with other retroviruses
(Dewannieux et al., 2006; Lee et al., 2008). Furthermore, it has
very recently been shown that the HML-2 envelope can prevent
the retention and degradation of particles usually caused by
tetherins (Lemaitre et al., 2014).
In the present study, we examined a broad range of cell lines
from 16 distinct tissues and ten species for their susceptibility to
HML-2 Env mediated infection. In addition, we tested the cellular
receptors of the most closely related betaretroviruses MMTV, JSRV
and ENTV for their potential to facilitate entry and for the ﬁrst
time provide evidence for the expression of a cellular inhibitor
that acts at a post-entry, pre-integration step on this virus.Results
The HML-2 envelope protein confers broad cell tropism
After attachment to a potential host cell a retrovirus must
interact with a suitable surface receptor via its envelope protein to
initiate entry. This interaction triggers the fusion of the viral
membrane with the cell membrane, bringing the viral core into
the cell cytoplasm. Although cell tropism is determined by mul-
tiple factors at various stages of the replication cycle, the expres-
sion of a functional receptor is of the upmost importance. We and
others have shown that reconstituted HML-2 envelope proteins
(Fig. 1) are able to mediate entry of retroviral particles into cells,
implying the expression of a functional receptor that has yet to be
identiﬁed (Dewannieux et al., 2006; Hanke et al., 2009; Lee and
Bieniasz, 2007). We have now undertaken a more systematic
analysis of the virus's cell tropism and host range as determined
by the expression proﬁle of the receptor. We used a C-terminally
truncated and codon-optimized oricoEnvΔ659–699 glycoproteinFig. 1. Proviral genome and domain structure of the HERV-K113 oricoEnv protein.
The Env precursor protein consists of the N-terminal signal peptide (SP), the sur-
face unit (SU) and the transmembrane subunit (TM) with the hydrophobic mem-
brane-spanning domain (MSD). The precursor protein is processed by cellular furin
proteases at the cleavage site (CS) that has the amino acid motive R-X-K/R-R. The
positions of nine potential glycosylation sites (N-X-S/T) within the Env molecule
are indicated. The oricoEnvΔ659–699 mutant was created by insertion of a stop
codon after the threonine at position 658 to increase incorporation of Env into
lentiviral particles.(Hanke et al., 2009) that is incorporated into SHIV reporter par-
ticles with a higher efﬁciency than the full-length HML-2 envelope
and facilitates efﬁcient and speciﬁc entry into susceptible host
cells (Hanke et al., 2009).
Since the SIV LTR activity that drives the luciferase reporter
expression in transduced cells is cell type dependent, we included
normalized VSV-G pseudotyped particles and calculated the rela-
tive degree of entry, which, to a certain degree, also corrects for
the effects of post-entry inhibitors. VSV-G pseudotyped lenti-
viruses have an extremely broad host range and were able to
efﬁciently infect all cell lines tested in this study. Unspeciﬁc entry
into each cell line was determined using a previously published
(Bannert et al., 2001) nonfunctional HIV envelope protein
termed ΔKS.
Most of the cell lines tested from different species were per-
missive for entry mediated by the HML-2 envelope glycoprotein
(Fig. 2), although cells such as the human Hep-2, THP-1 or guinea
pig 104C1 cells were completely refractory to infection, suggesting
that a critical receptor is not expressed on these cells. Overall, the
data indicate that expression of the elusive HML-2 receptor is not
tissue speciﬁc because cells from various tissues and organs
including liver, prostate, muscle, kidney, lung, colon, thymus,
ovary, brain, bladder and skin plus ﬁbroblasts and germ cells are to
some extent permissive. Of the cells tested, feline CrFK and canine
Cf2Th cell lines were transduced with the highest efﬁciency and
lower, but signiﬁcant entry levels were clearly detectable in
human, murine and rat cells.
These results suggest that the HML-2 envelope has a broad
tissue tropism and host range. It is able to infect many different
cell types from various species in cell culture, suggesting that like
other known amphotropic viruses it uses a widely expressed
receptor.
Analysis of the MMTV and JSRV receptors for their ability to mediate
entry of HML-2
As closely related retroviruses often share the same receptors,
we evaluated the known receptor proteins for MMTV and JSRV
(the two betaretroviruses most closely related to HML-2) for their
ability to facilitate entry of the human endogenous retrovirus.
First, we determined whether transfection of mammalian cell
lines with appropriate expression plasmids resulted in expression
of the corresponding envelope glycoproteins and their incorpora-
tion into lentiviral reporter particles with comparable efﬁciencies.
HEK 293T cells were transfected with vectors that produce pseu-
dotyped SHIV reporter particles in combination with plasmids
encoding either the nonfunctional 'present-day' coEnv-V5 (Hanke
et al., 2009), the ancestral oricoEnv-V5, MMTVcoEnv-V5, a non-
functional MMTV coEnv F138A (that has a mutated receptor
binding domain (Zhang et al., 2003)) or JSRV coEnv-V5. Western
blotting of transfected cell lysates revealed that all envelope pro-
teins were expressed in transfected HEK 293T cells (Fig. 3A) but
that the processing of coEnv and oricoEnv into their viral SU and
TM subunits was less efﬁcient than that of MMTV and JSRV coEnv.
With the exception of the nonfunctional HML-2 coEnv that con-
tains inactivating postinsertional mutations, all retroviral glyco-
proteins were incorporated into virions (Fig. 3B) with MMTV
coEnv and JSRV coEnv being inserted exclusively as cleaved
glycoproteins.
The receptors speciﬁcally used to gain entry to host cells are
the transferrin receptor 1 (TfR1) for MMTV (Golovkina et al., 1998)
and hyaluronidase 2 (Hyal2) for JSRV (Rai et al., 2001). To test
whether either receptor mediates entry of HML-2, we cloned the
feline TfR1 (fTfR1) protein from highly permissive CrFK cells and
the canine Hyal2 (cHyal2) from Cf2Th cells. The receptor genes
were then inserted into a pcDNA3 expression vector with a
Fig. 2. Cellular tropism of HERV-K113 oricoEnvΔ659–699 pseudotyped SHIV reporter viruses. Luciferase expression was used for parallel infections of oricoEnvΔ659–699 and
VSV-G pseudotypes in a panel of 33 different target cell types from 10 distinct species. The asterisks represent cell lines that could not be transduced by the HML-2 Env
pseudotyped lentivirus. The means and standard deviations of six replicates and at least three independent experiments are shown. Relative entry was calculated as
described in the materials and methods section.
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(huHyal2) were used as positive controls for the entry of pseu-
dotypes carrying MMTV and JSRV envelope proteins. JSRV is able
to use the human Hyal2 for entry (Miller, 2008) but human TfR1
cannot be used by MMTV (Wang et al., 2008a) and was therefore
used as a negative control.
To test whether TfR1-V5 expression increases HML-2 entry into
HEK 293T, cells were transfected with plasmid DNA encoding
hTfR1, fTfR1 or mTfR1 or with plasmids expressing cHyal2 or
hHyal2. Twenty-four hours later, Western blot analysis conﬁrmed
a strong and similar expression of each TfR1 (Fig. 3C) and Hyal2
(Fig. 3D) receptor versions and the transfected cells were infected
with normalized SHIV luciferase reporter constructs carrying dif-
ferent envelope proteins. As shown in Fig. 3E, all of the TfR1-V5
variants failed to increase entry of the oricoEnvΔ659–699 pseudo-
types although, as expected, expression of the murine TfR1 ren-
dered the virtually nonpermissive human HEK 293T cells highly
permissive for MMTV Env mediated entry, with an entry efﬁciency
two orders of magnitude higher compared to cells expressing the
human or feline receptors (Fig. 3E). These results demonstrate the
functionality of the mTfR1 receptor and show that the MMTV
receptor is not used by HML-2 for entry.
In a similar experiment designed to investigate the role of
Hyal2 in HML-2 entry, HEK 293T cells expressing cHyal2-V5 and
hHyal2-V5 were at least 80-times more susceptible to entry by
JSRV Env pseudotyped SHIV particles than mock transfected con-
trol cells (Fig. 3F) that show only a very low level of infection,
indicating receptor expression. In contrast, normalized
oricoEnvΔ659-699 pseudotypes could not infect Hyal2-V5 expres-
sing cells. None of the TfR1 or Hyal2 variants, when expressed by
the target cells, had a signiﬁcant effect on the entry of VSV-G
pseudotyped reporter viruses.
Taken together the results suggest that neither the transferrin
receptor 1 nor the hyaluronidase 2 receptor proteins facilitate the
entry of HML-2.Post-entry, pre-integration inhibition of HML-2
Although entry of lentiviral pseudotypes carrying the HML-2
Env glycoprotein indicates that most cells express a suitable
receptor protein, the same cells remained refractory to entry by
HML-2 based reporter viruses (Fig. 4A). It was therefore important
to determine whether or not reverse transcription products are
present in cells transduced with HML-2 reporter viruses. Using
primer pairs that amplify early RT reaction products (minus strand
strong stop DNA) retrotranscribed HML-2 DNA was identiﬁed in
feline CrFK cells transduced with VSV pseudotyped cores, but not
with cores pseudotyped with a nonfunctional envelope protein
(Fig. 4B). Moreover, VSV pseudotyping resulted in substantial
expression of luciferase- and GFP-reporter proteins, demonstrating
the inherent ability of the virions to proceed through the sub-
sequent post-entry steps essential for expression of the reporter
gene. However, this does not necessarily demonstrate integration
since reporter gene expression can result from unintegrated epi-
somal HERV-DNA. The ability of reconstituted VSV-pseudotyped
HML-2 virions to successfully integrate into the cell genome has
already been demonstrated by others (Brady et al., 2009;
Dewannieux et al., 2006; Lee and Bieniasz, 2007), but to the best of
our knowledge this has so far not been shown using HML-2 par-
ticles bearing their own envelope protein.
A potential reason for a restriction of HML-2 could be the
activity of cellular factors that target post-entry, pre-integration
steps. The activity of such inhibitors can be partially overcome by
infection with a decoy variant, resulting in an excess of viral tar-
gets in the cell to which the inhibitor can bind. Under such cir-
cumstances the probability of successful transduction increases
(Fig. 4C). To test the inhibitor hypothesis, luciferase HML-2
reporter viruses pseudotyped with oricoEnvΔ659–699 or VSV-G
and GFP-decoy HML-2 viruses pseudotyped with VSV-G were
generated and used to infect three cell lines that, based on the
results shown in Fig. 2, express substantial levels of the HML-2
receptor. Experiments were performed as single infections with
Fig. 3. Effects of the expression of V5-taged TfR1 and Hyal2 variants on the entry of HML-2 EnvΔ659–699 pseudotyped lentiviruses into HEK 293T cells. (A) Expression of
envelope proteins of HML-2, MMTV and JSRV in cells producing SHIV reporter particles. An immunoblot with lysates of cells used to produce SHIV reporter viruses
pseudotyped with the respective Env-V5 expression plasmids is shown. (B) Env incorporation into SHIV-particles. The corresponding supernatants were pelleted by
ultracentifugation. All Env proteins are linked to a V5-tag and were visualized by a V5-HRP antibody. To determine the particle load, the blot was stripped and incubated with
an SIV Gag (p27)-speciﬁc antibody. (C) Western blot analysis of lysates of HEK 293T cells transfected with human, feline and murine TfR1. The TfR1 proteins were detected by
anti-human TfR1 (huTfR1), anti-V5 (fTfR1) and anti-mouse TfR1 antibodies. (D) Western blot analysis of lysates of HEK 293T cells transfected with canine and human Hyal2-
expression vectors. The Hyal2 proteins were detected with an anti-Hyal2 monoclonal antibody. (E) Entry analysis using normalized levels of pseudotyped SHIV-based
luciferase reporter viruses in cells expressing TfR1 variants. (F) Entry analysis using normalized levels of pseudotyped SHIV-based luciferase reporter viruses in cells
expressing Hyal2 variants. The means and standard deviations of six replicates of at least three independent experiments are shown. RLU, relative light units.
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included a 10-fold or 100-fold excess of GFP-decoy viruses.
As shown in Fig. 4C, the HML-2-EnvΔ659–699 pseudotyped
HML-2-based luciferase viruses transduced all three cell lines at
the same background levels established using nonfunctional ΔKS
pseudotypes. However, in the prescence of excess VSV-G pseu-
dotyped GFP-reporter viruses, transduction of feline CrFK cells by
the luciferase viruses was signiﬁcantly increased. For example,
increasing the level of VSV-pseudotyped GFP-decoy from 10 to
100 resulted in a 9-fold increase in transduction by the
oricoEnvΔ659–699 pseudotyped reporter virus (Fig. 4C). In the
human cell line Huh7 a signiﬁcant titration effect was also seen
with the oricoEnvΔ659–699 luciferase reporter but not with VSV-
pseudotyped reporter viruses. In contrast, the effect was conﬁned
to the VSV-pseudotyped reporter viruses with the human prostate
cell line LNCaP. A likely explanation for these somewhat dissimilar
results obtained using the three cell lines is diverse expression
levels of the elusive cellular inhibitor.Taken together, the presence of decoy virus during infection
facilitated speciﬁc entry of HML-2 reporter viruses carrying an
HML-2 envelope. This boost in infection with increasing amounts
of the decoy suggests the presence of cellular inhibitors for HML-2
in human and nonhuman cells that are able to intercept the virus
at a post-entry, pre-integration step.Discussion
Retroviruses use their envelope proteins to recognize a broad
variety of cell-surface proteins and carbohydrates and gain entry
into the cell (Overbaugh et al., 2001). Expression of these attach-
ment factors and receptors may be ubiquitous or may be restricted
to a limited range of cells. Although the ability to use homologous
receptors from other species is often observed, this usually
diminishes with the evolutionary distance (Levy, 1999). While
some retroviruses require only a single transmembrane protein as
Fig. 4. Evidence for the presence of a cellular inhibitor(s) acting at a post-entry, pre-integration step. (A) Schematic depiction of the luciferase and GFP expressing vectors
used to produce pseudotyped HML-2-based luciferase and GFP encoding reporter particles. (B) Detection of early reverse transcription products in feline CrFK cells
transduced with VSV-pseudotyped HML-2 cores. The experiment was performed twice with duplicates with similar results. Plasmid DNA (lane þ) or no DNA (lane ) were
used as positive and negative controls for the PCR, respectively; M¼100 bp marker. (C) Titration experiment (including a schematic overview) using GFP-encoding particles
as decoys for the inhibitor. Three different cell lines were infected with HML-2-Env (oricoEnvΔ659–699) or VSV-G pseudotyped HML-2-based luciferase particles together with
increasing concentrations of co-infecting VSV-G pseudotyped GFP particles (none, 10 or 100 the concentration of the luciferase particles). The means and standard
deviations of six replicates and four independent experiments are shown. The asterisks denote a signiﬁcant difference (pr0.001).
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receptor. During the entry process of many retroviruses, binding of
the envelope to the receptor protein induces endocytosis with
subsequent acidiﬁcation of the vesicle. This lower pH triggers
conformational changes leading eventually to membrane fusion
and release of the viral core into the cytoplasm. In some cases,
however, membrane fusion can already occur at the cell surface
(Overbaugh et al., 2001).
In contrast to most human and non-human exogenous retro-
viruses, the host range and the entry characteristics of HML-2 have
not yet been studied in detail and the attachment factors and
receptor proteins involved remain unknown. Using a reconstituted
and codon-optimized sequence of the HERV-K113 envelope pro-
tein encoding a fully fusogenic protein (Hanke et al., 2009), we
generated pseudotyped lentiviral particles and probed a panel of
33 cell lines from 10 species for the presence of a functional
receptor protein acting as the primary determinant of HML-2
tropism. Our results demonstrate a fairly broad expression of the
HML-2 receptor protein(s) in different tissues with only three cell
lines (Hep-2, THP-1 and 104C1) being refractory to infection. This
broad cell tropism is consistent with previously published data
showing HML-2 Env-mediated infection of human, murine, ham-
ster, squirrel monkey and cat cell lines (Dewannieux et al., 2006;
Lee and Bieniasz, 2007). In line with the classiﬁcation of murine
gammaretroviruses, HML-2 can therefore be regarded as ampho-
tropic. Moreover, the presence of over 3000 HML-2 elements in
the human genome makes it very likely that the receptor protein
(s) is expressed on human germ line cells, presumably allowing its
frequent and efﬁcient endogenization. Unfortunately, this broad
cell tropism sheds little light on the cell types and tissuesprimarily used by HML-2 for replication during its existence as an
exogenous retrovirus in infected ancient primate species.
Related retroviruses often share the same cell entry receptor
and can be assembled into interference groups (Overbaugh et al.,
2001). In an initial attempt to identify the HML-2 receptor we
therefore tested whether the proteins known to be used as
receptors by its closest betaretroviral relatives can facilitate entry
of HML-2. For this we have expressed/overexpressed the human
and the host-species versions of the MMTV and JSRV/ENTV
receptor proteins. Neither the MMTV receptor transferrin receptor
1 (Ross et al., 2002) nor hyaluronidase 2, the receptor or attach-
ment factor for the oncogenic sheep retroviruses (Miller, 2008; Rai
et al., 2001) increased infection of reporter viruses pseudotyped
with the reconstituted HERV-K113 envelope protein, although
entry of pseudotypes carrying the envelope proteins of the
respective virus were signiﬁcantly enhanced. These results indi-
cate that HML-2 is unable to bind to these proteins and use them
for cell entry. This lack of binding also rules out the possibility that
HML-2 Env triggers oncogenic processes by signaling though these
receptors, a phenomena that, in the case of MMTV and JSRV/ENTV,
can lead to mammary tumors or lung adenocarcinomas in their
host species (Miller, 2008; Ross et al., 2006). However, it does not
preclude a role for HML-2 in tumorigenesis by some other
mechanism.
Cell tropism of retroviruses is also largely determined by the
expression of antiviral inhibitors acting at a post-entry, pre-
integration step. These include the Fv1 protein that determines
the tropism of MLVs, APOBEC proteins and Trim5α that restricts in
a species dependent manner infection by several retroviruses
including HIV-1 in rhesus monkey cells (Best et al., 1996; Mangeat
et al., 2003; Stremlau et al., 2004). Among other adverse effects on
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leads to degradation of mature retroviral capsids after entry
(Stremlau et al., 2006). With the exception of APOBEC, these
inhibitors are usually expressed and act in the infected cell and the
antiviral effect can often be abrogated by saturation (Hatziioannou
et al., 2004; Towers et al., 2003). Using this approach we investi-
gated two human and one non-human cell line for evidence of a
saturable HML-2 inhibiting activity by infecting with a ﬁxed dose
of a single cycle luciferase reporter vector plus increasing amounts
of a related GFP vector. In all three cell lines co-infection with
decoy particles increased the infection seen with luciferase parti-
cles. In Huh7 cells this increase was only observed when infecting
with oricoEnvΔ659–699 pseudotyped HML-2 particles but not with
VSV-G pseudotyped particles. This indicates a modest expression
of the inhibitor that was unable to inhibit entry mediated by the
far more effective VSV-G envelope protein. Although the con-
siderably lower expression of the entry receptor on LNCaP cells
(Fig. 2) presumably precluded detecting entry of oricoEnv pseu-
dotypes, the effect of inhibitor saturation could be demonstrated
using the VSV-G pseudotyped HML-2 luciferase vector. In the
feline CrFK cells that are normally very permissive for receptor-
mediated infection by oricoEnv pseudotyped vectors (Fig. 2), the
saturation effect could be shown with both oricoEnv and VSV-G
pseudotyped HML-2 particles. Together, these results indicate for
the ﬁrst time the presence of one or more cellular factors able to
impair infection by HML-2 at an early post-entry step. The factor
(s) involved and the exact stage in the HML-2 replication cycle at
which it acts remains to be determined. Our data suggests inhi-
bition in the newly infected cell, which is in agreement with
previously published evidence for reverse transcription starting in
the HML-2 particle before infection (Dube et al., 2014).
The factor would appear not to be Trim5α since this protein
does not affect HML-2 infection (Lee and Bieniasz, 2007) but it
may well be one of the other members of the large Trim family of
proteins (Nisole et al., 2005).
Altogether, the results presented here contribute to our
knowledge of HML-2 tropism by demonstrating a broad species
and cell tropism of its envelope protein while excluding the
involvement of the receptors used by its nearest betaretroviral
relatives, MMTV and JSRV/ENTV. Furthermore, they provide the
ﬁrst evidence for the existence of an antiretroviral factor acting at
a stage following entry of HML-2 cores into the cell and before
completion of integration and protein expression.Materials and methods
Cell culture
Adherent mammalian DU145, HeLa, HEK 293T, Huh-7, RD,
SW1783, Tera-1, Cf2Th, MDCK, Vero, Cos-7, CrFK, FEA, NIH3T3, T145,
T85, RK13 and PK15 cells were cultured in complete Dulbecco's
Modiﬁed Eagle Medium (DMEM) containing 10% Fetal Bovine Serum
(FBS) and L-glutamine (2 mM). In all cases the media was supple-
mented with penicillin (50 U/ml) and streptomycin (50 mg/ml). Cell
culture media for SK-Mel 28 cells contains additional 1% Non Essential
Amino Acids (NEAA). Hep-2 and REF cell lines were grown in DMEM
containing 5% FBS and L-glutamine (2 mM). LNCaP, L-929, RAW, JH4
and 104C1 cells were cultured in Roswell Park Memorial Institute
Medium (RPMI-1640) supplemented with 10% FBS. The same RPMI-
1640 medium was used for adherent A549 and non-adherent THP-1
with the addition of L-glutamine (2 mM). GH, T24 and CHO cell lines
were cultured in Ham’s F12 containing 10% FBS and L-glutamine
(2 mM). Supplemented Earle's Balanced Salt Solution (EBSS) with 10%
FBS, L-glutamine (2 mM) and 1% NEAA were used for CaCo2 and
BHK21 cells.Generation of expression plasmids
The HERV-K113 Env expression constructs of codon-optimized
coEnv-V5, the putative ancestral (original) oricoEnv-V5 (pcDNAor-
icoEnv-V5) and the derived C-terminal truncation mutant
oricoEnvΔ659–699 have been described previously (Hanke et al., 2009).
The synthetic, fully codon-optimized versions of the MMTV Env
(Genbank AAF31475, strain C3H) and JSRV Env (Y18301, strain JS7)
were synthesized and cloned into a pcDNA3.1(þ) (Invitrogen)
expression vector by Genscript (New Jersey, USA). An additional
C-terminal V5-tag was cloned in-frame of the codon-optimized
MMTV Env and JSRV Env sequences using XhoI and XbaI restriction
sites to generate MMTVcoEnv-V5 and JSRVcoEnv-V5. Using the
QuikChange Multi Site-Directed Mutagenesis Kit (Agilent Technolo-
gies, Santa Clara, CA, USA) we introduced an amino acid substitution
of phenylalanine to serine at position 138 which inactivates the
MMTV envelope protein leading to a complete loss of viral infectivity
(Zhang et al., 2003). The resulting construct was designated
MMTVcoEnvF138A-V5.
Human HEK 293T, feline CrFK and canine Cf2Th cDNA was
isolated using the Omniscript RT Kit (Qiagen). The Homo sapiens
TfR1 (hTfR1) sequence (GenBank NM003234) was ampliﬁed with
speciﬁc hTfR1-F (ATG ATG GAT CAA GCT AGA TCA GC) and hTfR1-R
(TTA AAA CTC ATT GTC AAT GTC C) primers from HEK 293T cDNA
and Felis catus TfR1 (fTfR1, GenBank AF276984) with fTfR1-F (ATG
ATG GAT CAA GCC AGA TCA GC) and fTfR1-R (TTA AAA CTC ATT
GTC AAT ATC C) using cDNA from CrFK cells. Canis lupus familiaris
Hyal2 (cHyal2) sequence (GenBank XM_541876) was ampliﬁed
with primers cHyal2-F (ATG TGG GCA GGC CTG GGC CC) and
cHyal2-R (CTA TGA AGT CCA GGT GAG CAC CAG G) from canine
Cf2Th cell-derived cDNA. All ampliﬁed receptor sequences were
subsequently inserted into a pCR™4Blunt-TOPOs vector (Life
Technologies, Darmstadt, Germany) and ﬁnally cloned into a
pcDNA3 expression vector (Life Technologies, Darmstadt, Ger-
many). The fTfR1 sequence was inserted into a C-terminal V5-tag-
containing pcDNA3 plasmid. All constructs were conﬁrmed by
DNA sequencing. Mus musculus TfR1 in pcDNA3.1 was kindly
provided by S. Ross (Ross et al., 2002) and Homo sapiens Hyal2 in
pETE vector was a gift from E.R. Zaborovsky (Wang et al., 2008b).
The SIVmac based retroviral vectors pSIvec1ΔenvLuc, the HIV-
1-Rev expressing plasmid pCMV-Rev, the plasmid pSVIII-ΔKS
(expressing a non-functional HIV-1 envelope to allow determina-
tion of non-speciﬁc virus uptake) and VSV-G (expressing the gly-
coprotein of the Vesicular Stomatitis Virus) are described elsewhere
(Bannert et al., 2000).
The CMV promoter-driven expression plasmids pBSKor-
iHERV_Luci and pBSKoriHERV_GFP are based on the pBSKoriHERV-
K113 sequence (Chudak et al., 2013). To generate these constructs
the U3-region upstream of the LTR's own TATA box was sub-
stituted by the CMV promoter sequence upstream of the CMV
TATA box by mutagenesis PCR. Age I restriction sites were subse-
quently introduced at positions 6760 and 8463 of HERV-K113
(GenBank AY037928) by site-directed mutagenesis used to replace
the env gene sequence within by an expression cassette consisting
of the EF1α promoter plus either the luciferase gene or the eGFP
gene. To prevent splicing, the SD at position 1077 was mutated
(G1077A) as was the SD at position 6712 (T6710G and T6713A).
The Rec expression plasmid pcDNA3_oricoRec-V5 and the
expression plasmid pcDNAoricoHERV-K_GagProPol have been
described elsewhere (Chudak et al., 2013; Hanke et al., 2013).
Immunoblot analyses
4106 HEK 293T cells were seeded in 100 mm dishes. Twenty-
four hours later, cells were transfected with the appropriate
expression plasmid using the calcium phosphate method. At 24 to
P. Kramer et al. / Virology 487 (2016) 121–128 12736 h post-transfection, cells were lysed in 500 ml lysis buffer (1%
Triton X-100, 50 mM Tris HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, and
protease inhibitor mix (Roche, Penzberg, Germany) and cell debris
was removed by centrifugation. Cleared protein samples were
directly mixed with Laemmli sample buffer (BioRad Laboratories,
München, Germany), brieﬂy boiled, pelleted and subjected to SDS-
polyacrylamide gel electrophoresis (PAGE) and immunobloting. A
monoclonal anti-human TfR1/ CD71 (eBioscience San Diego CA, USA)
primary antibody was used to detect hTfR1 and goat anti-mouse
immunoglobulin G conjugated to horseradish peroxidase (HRP)
(Sigma-Aldrich, Taufkirchen, Germany) was used as a secondary
antibody. Blots to detect mTfR1 were probed with anti-mouse TfR1/
CD71 (eBioscience San Diego CA, USA) and then incubated with HRP-
conjugated immunoglobulin G raised against rat antibody (Sigma-
Aldrich, Taufkirchen, Germany). An anti-Hyal2 monoclonal antibody
(Abcam Cambridge, UK) followed by a secondary anti-rabbit IgG
conjugated to HRP was used to detect Hyal2 and an anti-V5-HRP
antibody (Invitrogen) was used to detect the V5 epitope included in
the envelope or receptor proteins. Blots were visualized using
enhanced chemiluminescence reagents (Life Technologies, Darm-
stadt, Germany).
Production of pseudotyped reporter particles and infectivity assay
HEK 293T cells seeded (7.5106 cells) 24 h previously into
150 cm2 cell culture ﬂasks were used to generate large stocks of
reporter viruses capable of a single round of infection. For SHIV-
based vectors the adherent cells were transfected with 50 mg of
pSIvec1ΔenvLuci, 11 mg pCMV-Rev and 2 mg of an appropriate
envelope expression vector using the calcium phosphate method.
At 48 h post-transfection, virus-containing supernatants were
collected, centrifuged at 450 g for 10 min and ﬁltered through
0.45 mm membranes to remove cell debris. For pseudotyped HML-
2 reporter particles, cells were transfected with 36 mg of pBSKor-
iHERV_Luci or pBSKoriHERV_GFP, 10 mg of pcDNAoricoHERV-
K_GagProPol, 10 mg of pcDNA3_oricoRec-V5 and 2 mg of the
respective envelope expression plasmid. Approximately 48 h post-
transfection the virus-containing supernatants were collected and
concentrated by ultracentrifugation through a 20% sucrose cushion
for 3 h at 4 °C and 175,000 g. The viral pellets were resuspended in
500 ml of DMEM and ﬁltered through a 0.45 mm membrane. Virus
preparations used for the detection of early RT products were
treated with RNAse free DNAse (Qiagen, Hilden, Germany) to
remove contaminating plasmid DNA. A Gag-speciﬁc enzyme-
linked immunosorbent assay (ELISA) or radioactive Quan-T-RT
assay (Perkin Elmer, Waltham, MA, USA) was used to assess and
normalize virus preparations. FACS analyses using normalized
luciferase and GFP reporter viruses demonstrated that an RLU of
104 corresponds to approximately 0.5% green cells in our assays.
For receptor and infectivity (titration) studies, eukaryotic cell
lines were seeded in 24-well plates (60% conﬂuence). The next
day, cells were rinsed with PBS and incubated with 400 ml nor-
malized virus supernatant and 200 ml fresh medium for 2 h.
Polybrene at 8 mg per ml was added to the cells. After removal of
the supernatants, the cells were cultured in regular medium for
the next 48 h at 37 °C. Early reverse transcriptase products were
determined by isolating DNA using the QIAamp DNA Mini and
Blood Kit (Qiagen, Hilden, Germany) and subsequent PCR using the
primers HervRU5_1649-1668_For: TACTAAGGGAACTCAGAGGC
and HervRU5_1802-1818_Rev: TGTAGGGGTGGGTTGCC. Infection
was determined by measuring the luciferase activity in cell lysates
using the Luciferase Assay System (Promega, Madison, WI, USA)according to the manufacturer’s instructions. The relative entry
was calculated using the following formula:
Relative entry¼ ðoricoEnvΔ659 699ΔKSÞðVSV GΔKSÞ ¼  10
7
The HML-2 receptor identiﬁcation study was performed in 24-
well plates of transiently transfected HEK 293T cells with 1 mg of
TfR1 and Hyal2 expression plasmids using the calcium phosphate
method. At 24 h post-transfection the cells were washed with PBS
and subsequently infected with normalized virus supernatant as
described above.Acknowledgments
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